The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early stage breast cancer (NCT01372579).
 
Virginia G. Kaklamani
Honoraria - Eisai
Consulting or Advisory Role - Eisai; Myriad Genetics
 
Elisha Hughes
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Kalliopi P. Siziopikou
No Relationships to Disclose
 
Kirsten Timms
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Victor Abkevich
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Cara Solimeno
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Anne-Renee Hartman
No Relationships to Disclose
 
Jacqueline Jeruss
No Relationships to Disclose
 
Caitlin Meservey
No Relationships to Disclose
 
Borko Jovanovic
No Relationships to Disclose
 
Irene B. Helenowski
No Relationships to Disclose
 
Seema Kahn
No Relationships to Disclose
 
Kevin P. Bethke
No Relationships to Disclose
 
Nora Hansen
No Relationships to Disclose
 
Regina Uthe
No Relationships to Disclose
 
Steven Rosen
No Relationships to Disclose
 
Kent Hoskins
No Relationships to Disclose
 
Jamie Von Roenn
No Relationships to Disclose
 
Sarika Jain
No Relationships to Disclose
 
William John Gradishar
No Relationships to Disclose